CBMX Key Stats
|Revenue (Quarterly YoY Growth)||16.06%|
|EPS Diluted (TTM)||-4.37|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-5.312M|
|Gross Profit Margin (Quarterly)||43.78%|
|Profit Margin (Quarterly)||-90.15%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- 6:02 am CombiMatrix announces the American College of Obstetricians and Gynecologists now recommends microarray analysis as first-line genetic testing Dec 5
- Unusual 11 Mid-Day Movers 12/05: (CALI) (PBYI) (MEI) Higher; (SOL) (WTSL) (NWY) lower Street Insider Dec 5
- CombiMatrix says ACOG recommends microarray analysis as first-line testing Dec 5
- CombiMatrix (CBMX) Stock Gains Following ACOG Recommendation Street Insider Dec 5
- American College of Obstetricians and Gynecologists Recommends Microarray Analysis as First-Line Genetic Testing noodls Dec 5
- InPlay: CombiMatrix announces the American College of Obstetricians and Gynecologists now recommends microarray analysis as first-line genetic testing Dec 5
- COMBIMATRIX CORP Files SEC form 8-K, Unregistered Sale of Equity Securities Nov 27
- Unusual 11 Mid-Day Movers 11/22: (ATRM) (PVG) (ARIA) Higher; (VMEM) (TFM) (DLIA) Lower Street Insider Nov 22
- Unusual 11 Mid-Day Movers 11/21: (CBMX) (BONT) (ONVO) Higher; (SGOC) (FU) (LQDT) Lower Street Insider Nov 21
- CombiMatrix (CBMX) Surges on New Deal Street Insider Nov 21
CBMX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). CombiMatrix is down 66.51% over the last year vs S&P 500 Total Return up 29.87%, Affymetrix up 155.3%, and Life Technologies up 51.08%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for CBMX
Pro Strategies Featuring CBMX
Did CombiMatrix make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
CombiMatrix Corporation is a molecular diagnostics company that operates mainly in the field of genetic analysis and molecular diagnostics.